Evidence map›Paper›PMID 36161910›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2022

Dual roles of β-arrestin 1 in mediating cell metabolism and proliferation in gastric cancer.

Huan Yu, Man Wang, Ting Zhang, Lihua Cao, Zhongwu Li, Yang Du, Yanru Hai, Xiangyu Gao, Jiafu Ji, Jianmin Wu

Abstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Review
  6. Article
  7. Review
  8. GPCR Biased Signaling in Cancer.Handbook of experimental pharmacology · 2026
    Review
  9. Article
  10. Article
  11. [Development and dissemination of precision medicine approaches in gastric cancer management].Beijing da xue xue bao. Yi xue ban = Journal of Peking University. Health sciences · 2025
    Article
  12. Review
  13. Review
  14. Review
  15. Review
  16. Review
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Huan YuKey Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Center for Cancer Bioinformatics, Peking University Cancer Hospital & Institute, Beijing 100142, China.
Man WangKey Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Center for Cancer Bioinformatics, Peking University Cancer Hospital & Institute, Beijing 100142, China.
Ting ZhangKey Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Center for Cancer Bioinformatics, Peking University Cancer Hospital & Institute, Beijing 100142, China.
Lihua CaoKey Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Center for Cancer Bioinformatics, Peking University Cancer Hospital & Institute, Beijing 100142, China.
Zhongwu LiDepartment of Pathology, Peking University Cancer Hospital & Institute, Beijing 100142, China.
Yang DuKey Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Center for Cancer Bioinformatics, Peking University Cancer Hospital & Institute, Beijing 100142, China.ORCID 0000-0002-5307-448X
Yanru HaiKey Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Center for Cancer Bioinformatics, Peking University Cancer Hospital & Institute, Beijing 100142, China.
Xiangyu GaoGastrointestinal Cancer Center, Peking University Cancer Hospital & Institute, Beijing 100142, China.ORCID 0000-0002-1697-1157
Jiafu JiGastrointestinal Cancer Center, Peking University Cancer Hospital & Institute, Beijing 100142, China.
Jianmin WuKey Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Center for Cancer Bioinformatics, Peking University Cancer Hospital & Institute, Beijing 100142, China.ORCID 0000-0002-8876-128X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

β-Arrestin 1 (ARRB1) has been recognized as a multifunctional adaptor protein in the last decade, beyond its original role in desensitizing G protein-coupled receptor signaling. Here, we identify that ARRB1 plays essential roles in mediating gastric cancer (GC) cell metabolism and proliferation, by combining cohort analysis and functional investigation using patient-derived preclinical models. Overexpression of ARRB1 was associated with poor outcome of GC patients and knockdown of ARRB1 impaired cell proliferation both ex vivo and in vivo. Intriguingly, ARRB1 depicted diverse subcellular localizations during a passage of organoid cultures (7 d) to exert dual functions. Further analysis revealed that nuclear ARRB1 binds with transcription factor E2F1 triggering up-regulation of proliferative genes, while cytoplasmic ARRB1 modulates metabolic flux by binding with the pyruvate kinase M2 isoform (PKM2) and hindering PKM2 tetramerization, which reduces pyruvate kinase activity and leads to cellular metabolism shifts from oxidative phosphorylation to aerobic glycolysis. As ARRB1 localization was shown mostly in the cytoplasm in human GC samples, therapeutic potential of the ARRB1-PKM2 axis was tested, and we found tumor proliferation could be attenuated by the PKM2 activator DASA-58, especially in ARRB1

Indexed as

beta-Arrestin 1Pyruvate KinaseStomach NeoplasmsCell Line, TumorCell ProliferationE2F1 Transcription FactorGlycolysisHumansProtein IsoformsReceptors, G-Protein-CoupledARRB1 protein, humanbeta-Arrestin 1E2F1 Transcription FactorProtein IsoformsPyruvate KinaseReceptors, G-Protein-CoupledARRB1cell proliferationgastric cancermetabolic reprogrammingPKM2

Identifiers

PMID36161910
PMCPMC9546581

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.